Lattice Biologics Ltd. (LBLTF)

0.0587 -0.0299 (-33.75%) At close: 2:20PM EST

Lattice Biologics Ltd.

512 East Madison Avenue
Suite 101
Belgrade, MT 59714
United States
406 570 2658
http://www.latticebiologics.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Guy S. Cook	Chairman, Pres & CEO	360k	N/A	1965
Ms. Donna Medina	Interim Chief Financial Officer	60k	N/A	N/A

Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. The company offers AmnioBoost, an allograft amniotic fluid visco supplement for the treatment of joint pain associated with osteoarthritis, as well as traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix allografts. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair in burn victims, hernia repair, and subchondral bone defect repair in knee and other joint surgeries, as well as sports medicine indications, such as anterior and posterior cruciate ligament repair. The company is headquartered in Belgrade, Montana.

Corporate Governance

Lattice Biologics Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.